Caroline Seydel, Contributor

The Seattle-based startup draws on principles of protein design and cellular control to improve targeted cell therapies

Undiagnosed genetic diseases take a serious physical and emotional toll on families. Rapid genome sequencing can provide answers and guide treatment decisions, but so far, insurance companies have been reluctant to pay. That’s beginning to change.

New research shows how a key component of the brain’s reward-processing system changes in response to light exposure. The finding could have implications for understanding mood disorders, addiction-related behaviors, and suicide.

Four extraordinary students share how their passion for asking questions and refusal to give up earned them national recognition in the Regeneron 2021 Science Talent Search

Alay Shah of Plano West Senior High School, Plano, TX, designed AI algorithms to detect eye movement differences in people with various neurological conditions. The invention earned him seventh place at the 2021 Regeneron Science Talent Search.

20 years after their first attempt, UCSD researchers are trying again with a more powerful drug and a more effective delivery method.

By mapping out which genes are active in specific cells over the course of development, scientists can better understand how brain cells establish connections.

By establishing funding and production pipelines now, Thailand will be well-positioned to quickly produce a vaccine the next time a pandemic erupts.

Scientists at Neoleukin Therapeutics applied their protein design technology to the new coronavirus and created an antiviral molecule in record time.